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The gallium(III)-salicylidene acylhydrazide complex shows synergistic anti-biofilm effect and inhibits toxin production by Pseudomonas aeruginosa Biofilm is a bacterial growth mode characterized by formation of organized cell clusters coated with extracellular polymeric substances. According to National Institute of Health biofilms are responsible for up to 80% of all infections, which often become chronic and difficult to eradicate [1] . Extracellular polymeric substances enable bacteria to attach to surfaces e.g. prosthetics, catheters, and tissues, and protect them from antibiotics and host immunity. Another explanation for biofilm persistence and resistance to antibiotics is the slower metabolism and distinct gene expression of sessile bacteria in biofilms compared to their planktonic, free-swimming, counterparts [2] [3] [4] .
Among bacteria that cause biofilm-associated infections Pseudomonas aeruginosa is one of the most ubiquitous. P. aeruginosa is an opportunistic human pathogen causing many types of infection e.g. in burn wounds [5] , and immunocompromised patients [6, 7] . It causes life-threatening pneumonia in cystic fibrosis patients [8] and is one of the most common pathogens infecting foot ulcers in patients with diabetes mellitus, resulting in frequent foot and leg amputation [9] . Multi-drug resistant P. aeruginosa strains represent a serious problem in healthcare with no effective antibiotic treatments available. Thus, the need for new antimicrobial drugs and targets for treatment of these multi-resistant strains is urgent and should not be underestimated.
Pathogens such as P. aeruginosa, Francisella tularensis, and Mycobacterium tuberculosis are very sensitive to Fe limitation since Fe plays an important role in the active center of many of their enzymes and respiratory proteins [10] [11] [12] . Consequently, limiting Fe(III) availability is an efficient method used by the human body to control infection [13, 14] . In mammalian body fluids the level of free iron is very low as it is Journal of Inorganic Biochemistry 138 (2014) [1] [2] [3] [4] [5] [6] [7] [8] bound to proteins such as transferrin and lactoferrin that have high affinity to Fe(III) (binding constants log K~20) [13, 15] . The levels of free Fe in different fluids vary between individuals and time points but in a study of 50 healthy adults it was found that the non-protein bound Fe concentration was between 0 and 18 μM in plasma, 0-14 μM for amniotic fluid, 0-11 μM for bronchoalveolar lavage and 0-0.59 μM for brain tissue with median values of 1.8 μM, 1.45 μM, 0.50 μM and 0.08 μM respectively [16] . Limitation of Fe has been shown to prevent and disperse biofilms in P. aeruginosa. Bacteria in the depth of a biofilm are starved due to Fe restriction, and dispersal has been suggested through induction of twitching motility [17, 18] . Fe(III) restriction can also be achieved through the addition of Fe(III) antagonists. Ga(III) is an Fe(III) mimetic that is proposed to be taken up into bacterial cells through Fe(III) transport mechanisms such as siderophores and thereafter interfere with metabolic systems requiring Fe(III) [19] . Exposure of P. aeruginosa to Ga(III) has been shown to inhibit bacterial growth and biofilm formation [20] [21] [22] .
The hydrazone substances, investigated, here have in common a chelating motif in the center of the molecule that can bind metal ions such as Fe(III) and Ga(III) (Fig. 1) . Substances with similar chelating motif have been tested as Fe(III) chelators for treatment of Fe(III) overload in patients due to their high binding constants to Fe [23] [24] [25] . Additionally, hydrazones were shown to inhibit type III secretion system (T3SS) in a range of Gram-negative bacteria [26] . T3SS is a protein complex used for delivery of bacterial toxins into the host cell, and it is a virulence factor that enables the pathogen to infect a host and cause disease. Inhibiting T3SS prevents toxin delivery and, hence, makes bacteria less harmful. The mechanism of action for anti-virulence hydrazones is still to a large extent unknown. Recent studies have shown that these compounds bind to several proteins, suggesting multiple targets in the bacterial cell [26, 27] . Fe chelation by hydrazones has been shown to inhibit growth and T3SS in sexually transmitted pathogens (Chlamydia trachomatis and Neisseria gonorrhoeae) [28] . The involvement of Fe in the expression of T3SS in these species is unclear while in other species, Fe depletion stimulates the expression of T3SS through genetic cascades [29] . Hydrazones have also been described to restrict Fe from mammalian tumor cells and it was observed that treatment of tumor cells with a combination of hydrazones and Ga(III) enhanced the effect, indicating possible synergies [30] [31] [32] [33] [34] .
In this study we screened Fe(III) chelating hydrazones, described earlier [26] , in the presence of Ga(III) ions and show that the antibacterial and anti-biofilm effects were enhanced. The presence of a Ga(III)-hydrazone complex was evidenced from extended X-ray absorption fine structure (EXAFS) spectroscopy, which shows that Ga(III) binds to the chelating motif in the hydrazone.
Methods

Chemicals
Chemicals were purchased from Sigma-Aldrich and used without purification unless otherwise stated. Hydrazones were synthesized according to Dahlgren et al. [26] and Nordfelth et al. [35] . All solutions were prepared from deionized and boiled water (resistance = 18.2 MΩ) at an ionic strength of 0.1 M NaCl (Merck p.a., dried at 453 K). A 30 mM HCl solution in 0.1 M NaCl was made from concentrated HCl (37% Aldrich) and standardized against tris(hydroxymethyl) aminomethane (Trizma base). A 10 mM NaOH solution in 0.1 mM NaCl (degassed with N 2 (g)) was made from a 50% NaOH solution and standardized against the standardized HCl solution. A 10.6 mM Ga(NO 3 ) 3 solution was prepared from Ga(NO 3 ) 3 xH 2 O (Aldrich) in 0.1 M NaCl and 40.5 mM NaOH, giving Ga(III) in the form of the soluble Ga(OH) 4 − ion.
The exact concentration of Ga(III) was determined by using Atom Absorption Spectrometry (Perkin Elmer AAS 3110).
Solubility screening
Hydrazone precipitation in aqueous solution was screened to identify which compounds would be soluble during the experimental conditions for the study. For this, 100 μM solutions of hydrazones in ISO-SENSITEST medium were incubated at room temperature for 24 h and the turbidity of the solutions was measured at 600 nm. Screening for Fe(III) binding can be found in supporting material.
Bacterial growth conditions and biofilm experiments
P. aeruginosa, PAO1, was routinely cultured on blood agar plates. ISO-SENSITEST broth and tryptic soy broth (TSB) were used when growing bacteria in liquid cultures. Iron-free medium was prepared according to Rzhepishevska et al. [21] with small modifications. Standard ISO-SENSITEST (100%) was used and the concentrations of the trace element solutions were adjusted to the following final concentration: 0.03 mM MgSO 4 ; 0.08 μM ZnCl 2 ; 0.01 μM CuSO 4 ; 0.05 μM MnCl 2 ; 0.25 μM CaCl 2 .
Minimal inhibitory concentration (MIC) that suppresses 90% of bacterial growth (MIC 90 ) of Ga(III) 2-Oxo-2-[N-(2,4,6-trihydroxybenzylidene)-hydrazino]-acetamide (Ga(III)-ME0163) was measured as described by Rzhepishevska et al. [21] and inhibition of P. aeruginosa biofilm formation was assessed by two methods. Method one: P. aeruginosa PAO1 expressing green fluorescence protein (GFP) was used for screening biofilm inhibition [26] . Bacteria were cultured in multi-well plates with shaking in the presence of Ga-hydrazone complexes. Growth was measured as culture absorbance at 600 nm (OD 600 ) after the medium with planktonic bacteria was carefully removed. The amount of biofilm was measured as a fluorescent signal from GFP at 515 nm. No washing step was included to avoid loss of loosely attached biofilm. Method two: to confirm screening results we used a standard crystal violet staining assay. Briefly, 1 ml of ISO-SENSITEST broth containing Ga(III)-citrate, Ga(III)-ME0163, and ME0163, was inoculated with overnight culture of P. aeruginosa PAO1 and incubated in a humidified shaker at 37°C. Crystal violet solution (0.1%) was added to each well of a 24-well plate, incubated for 10 min, rinsed with phosphate buffered saline (PBS) and air dried. Crystal violet was dissolved in 33% acetic acid and absorbance of the solutions was measured at 595 nm. The biofilm assay was done in 20% ISO-SENSITEST with the addition of tetracycline 10 μM to support the plasmid for GFP expression. 
Exposure of mammalian cell lines to different hydrazones
To evaluate cytotoxicity and the inflammatory response of mammalian cells to 4-Methyl-[1,2,3]thiadiazole-5-carboxylic acid (6-bromo-2-hydroxy-3-methoxy-benzylidene)-hydrazide (ME0150), 3-(4-Hydroxy-phenyl)-propionic acid (2,4,6-trihydroxy-benzylidene-) hydrazide (ME0161), ME0163 and 3-Methoxy-benzoic acid (3,5-ditert-butyl-2-hydroxy-benzylidene)-hydrazide (ME0184), we used three different cell lines: BEAS-2B (human bronchial epithelial cells), A549 (human alveolar epithelial cells) and L929 (mouse fibroblast cells). BEAS-2B cells were cultured in serum-free bronchial epithelial cell basal medium with supplements (complete medium, BEGM Cambrex,Verviers, Belgium). A549 and L929 cells were grown as previously described [21] . Cell viability/cytotoxicity was measured using the AlamarBlue assay (Serotec Scandinavia, Kidlington, United Kingdom) [21] . Stock solutions of ME0150, ME0161, ME0163 and ME0184 were diluted in culture medium to a final concentration of 10 μM, 50 μM, 100 μM and 200 μM and added to the cells in 8 replicates. Proinflammatory cell response was analyzed by monitoring the release of interleukin 8 (IL-8), and interleukin 6 (IL-6) using enzyme-linked immunosorbent assay (ELISA R&D Systems, Abingdon, United Kingdom) [21] .
EXAFS spectroscopy data collection and analysis
Samples for EXAFS were prepared by adding a high pH 10.6 mM Ga(OH) 4 − solution and 10 mM NaOH solution into a solution of 
Density functional theory (DFT) calculations
A geometry optimization of the neutrally-charged Ga(OH) 2 1 + -
is the completely deprotonated ME0163 ligand and Ga(III) is in 5-and 6-membered chelate coordination) was carried out at the B3LYP/6-31G level of theory [38] . A water molecule was added to this complex to complete the octahedral coordination shell of Ga(III). Calculations were carried out using Gaussian 09 [39] .
Induction and analysis of type three secretion system (T3SS)
T3SS was induced by low calcium growth conditions (TSB broth with EGTA and 5 mM MgCl 2 ) as described by Lee et al. [40] . P. aeruginosa PAO1 was grown to OD 600 of 1.9, bacteria were pelleted and culture supernatant (1.8 ml) was used for analysis of the secreted proteins. Secreted proteins were precipitated from supernatant by 10% trichloroacetic acid, washed with acetone and re-suspended in 100 μl loading buffer for electrophoresis [33, 41, 42] . At the same time, aliquots of the culture containing both bacteria and the supernatant (100 μl) were collected and mixed with the loading buffer to analyze total (expressed and secreted) protein. Protein fractions were separated on NuPAGE ready-made gradient gels (Novex, Life Technologies) and ExoS protein, a marker of T3SS expression and secretion, was detected using Western blot with ExoS antibody. Total protein fraction was additionally analyzed using FliC (H7) antibody as a control of protein expression in the presence of Ga(III) complexes at 50 μM (1:1 complex). All experimental conditions (cultures, optical density measurements and secreted protein analysis) were performed in triplicates. Total protein was analyzed in duplicates.
Results and discussion
Hydrazone Fe(III) binding ability
A hydrazone collection of 54 compounds, obtained by statistical molecular design and subsequent synthesis [26] , was screened with excess hydrazone to assess Fe(III) binding (Table S2 in supporting material). For most hydrazones, Fe(III) complexes were formed to different extents. For example, in the 1:2 Fe:hydrazone mixture used, ME0161 gave a 1:1 ratio between free ligand and complex indicating possible formation of a 1:1 Fe:hydrazone complex. However, no Fe(III) complex was detected for the hydrazone ME0163 under the experimental conditions used.
Antibiofilm and antibacterial effects of Ga(III)-hydrazone complexes
Since complex formation with Fe(III) varied for different hydrazones (Table S2 ) it could be expected to vary also for Ga(III). Hence in the next step the hydrazone library was screened for the most efficient Ga(III) complex with respect to anti-biofilm effects on P. aeruginosa. First, compounds with good solubility in aqueous media were selected as we observed that some hydrazones precipitated in these conditions. Thereafter, 1:1 Ga(III):hydrazone mixtures at different concentrations were studied for effect on growth and biofilm formation of P. aeruginosa ( Fig. 2 and Fig. S1 ). A solution with Ga(III)-citrate complexes was used as a reference since it has previously been reported to have both antibacterial and antibiofilm properties [21] . A large inhibition of planktonic growth was seen for ME0150 and ME0184 at concentrations higher than 6 μM (Fig. 2 ). An anti-biofilm effect could be observed for most of the tested compounds already at 3 μM of Ga(III)-hydrazone although the effect was similar to that obtained with Ga(III)-citrate. ME0161 and ME0163 showed the largest antibiofilm effect at several different concentrations, displayed an enhanced antibiofilm effect compared to the Ga(III)-citrate control, and had little effect on growth (Figs. 1 and  2 ). The increased activity of ME0163 with Ga(III) suggested that it could form metal complexes even if an Fe(III) complex was not detected in the aforementioned Fe(III) binding assay.
Cytotoxic effects on human cells
For any application in medicine it is important that the substance is not toxic to mammalian cells. The hydrazones alone have previously been screened for toxicity to HeLa cells [26] , but we were interested to look into the toxicity of the hydrazones with and without Ga(III) to epithelial cells (that could be expected to become exposed to these substances were they to be used topically or on medical devices). Consequently, we studied cytotoxicity and inflammatory response on human bronchial epithelial cells (BEAS-2B), alveolar epithelial cells (A549) and mouse fibroblast cells (L929 -a common reference cell line). Compounds ME0150 and ME0184 that had a large effect on bacterial growth were also toxic to mammalian cells (Fig. S2) and were therefore excluded from further investigations. However, compounds ME0161 and ME0163 in the presence of gallium were not found to be cytotoxic (Fig. S3) nor produce inflammatory responses when tested on bronchial or alveolar cells (data not shown). No toxicity to bronchial epithelial cells was seen even in the absence of serum, which is an important observation since serum has been reported to protect cells from antibiotic toxicity by metal ions in vitro [43] .
Antibiofilm and antibacterial effects of the complex Ga(III)-ME0163
After the screening we focused on ME0163 with Ga(III) as it had better anti-biofilm properties compared to Ga(III)-citrate, exhibited no cytotoxic effect on mammalian cells, and since the solubility of ME0163 enabled detailed thermodynamic studies of protonation and metal binding (reported in Hakobyan et al. [44] ). First, the data from the biofilm screening was confirmed using a second method, i.e. the traditional crystal violet assay. Both biofilm assays showed that Ga(III)-ME0163 inhibited biofilm formation more efficiently at low concentrations than Ga(III)-citrate did, while ME0163 alone had very little effect on biofilm formation (Fig. 3a) . Bacterial growth curves showed that Ga(III)-ME0163 inhibited growth of P. aeruginosa more efficiently than Ga(III)-citrate at a concentration of 50 μM (Fig. 3b) while at 12.5 μM the inhibition was comparable between the two Ga(III) complexes. These results are consistent with previous studies of Ga (III) showing that lower concentrations of Ga(III) are needed to prevent biofilm formation than to inhibit growth [21] . Thus, the results indicate that when used together with ME0163, the anti-biofilm action of Ga(III) is achieved at lower concentrations. At higher concentrations, e.g. 50 μM, the difference in biofilm inhibition becomes masked by growth inhibition.
Since both compounds are described as Fe antagonists and the medium diluted to 20% will have a low amount of Fe, we also investigated the antibacterial effect in standard (100%) medium, that contains~6-7 μM Fe, and standard medium treated with Chelex-100, a resin that binds free Fe. In standard ISO-SENSITEST MIC 90 for both Ga(III)-ME0163 and Ga(III)-citrate was 200 μM, but in Fe-free ISO-SENSITEST, MIC 90 was 100 μM for Ga(III)-ME0163 and 200 μM Ga(III)-citrate. In Fe-free Table S1 ) on (from left) biofilm formation (red bars) and growth of PAO1 in solution (blue bars) tested at a concentration of a) 25 μM, b) 12.5 μM, c) 6.12 μM, and d) 3 μM in 20% ISO-SENSITEST. Biofilm was judged by fluorescence of green fluorescence protein expressed by bacteria. "Control" is no Ga(III) or hydrazone and "Ga cit" corresponds to samples with Ga(III)-citrate (previously shown to inhibit both growth and biofilm formation [21] ). conditions 50 μM of ME0163 alone (Fig. 3c) inhibited growth of P. aeruginosa to some extent, while it had no effect on growth in 20% ISO-SENSITEST (Fig. 3b) . In both Fe restricted conditions (Fig. 3b and c) Ga(III)-ME0163 suppressed bacterial growth, indicating a synergistic inhibitory effect between Ga(III) ions and ME0163, especially in the Chelex-treated medium where Ga(III)-citrate had almost no effect on growth. An explanation for this lack of inhibition from Ga(III)-citrate could be that metabolic pathways for bacteria growing in chelated media may differ. Together with iron, Chelex-100 also binds organic compounds and concentrations of certain amino acids can be decreased up to 80% in growth media due to chelation [45] . This may cause bacteria to use another energy source (e.g. glucose) and express different enzymes. The alternative enzymes may be less affected by Ga(III) thereby decreasing bacterial sensitivity to gallium [21] .
The synergistic or additive effect of a Ga(III)-ME0163 complex could be accounted for in several ways: i) the presence of Ga(III) and formation of a Ga(III) complex solubilizes Ga(III) and/or the hydrazone to a larger extent or thereby increase the active concentration in solution for both substances, ii) the hydrazone and Ga(III) both act on Fe(III) sensitive systems (e.g. enzymes) and therefore the effect is enhanced when both substances are present, or iii) the complex has an increased effect caused by differences in uptake or target. The enhanced synergy effect in Fe-free conditions suggests that the first explanation is unlikely as the solubility should be similar or higher in the presence of Fe(III) since complexation of ME0163 with Fe(III) as well as Ga(III) would shift the solubility equilibrium towards soluble species. The second and third explanation seems more probable. Explanation ii) is possible since Fe(III) sensitive enzymes could be rescued at some base level of Fe(III) in the medium, thus suggesting a reason for the difference between 20% and 100% media, however, this does not clarify the difference between Ga complexes. The difference observed between Ga(III)-citrate and Ga(III)-ME0163 in chelated medium could be accounted for by hypothesis iii) and/or that the bacteria change carbon source in Chelex-treated medium. We showed previously that P. aeruginosa grown on glucose expresses approximately 4 times less pyoverdine than P. aeruginosa grown on Casamino acids [21] . Consequently, if P. aeruginosa loses the potent siderophore pyoverdine and free Fe(III) is sequestered by ME0163, it may experience iron starvation. While the mechanism of this process is outside the scope of this article, it is clear that ME0163 is a successful ligand for Ga(III) potentiating its antibacterial and anti-biofilm effects in both types of medium, and that the effect on biofilm occurs at lower concentrations than the effect on bacterial growth. Furthermore, considering that the 20% medium had free Fe levels corresponding to those measured in biological fluids, we can assume that the complex would still be effective in most biological fluids.
EXAFS analysis and DFT calculations of complex
The biological effects observed did not necessarily have to be a result of a Ga(III)-ME0163 complex but could also have been a combined effect of the two substances acting alone on the bacterial cell, especially since no Fe(III)-ME0163 complex was detected. However, a parallel study [44] showed strong complex formation at physiological pH (Fig. 4a) , with hydrazone binding constants to Ga(III) similar to that of EDTA. While those experiments were carried out under more dilute conditions than those considered in this work, the thermodynamic model generated in that study ought to be applicable to a wide range of concentrations. As concentrated systems can generate multinuclear species and/or solid phases that do not occur under more dilute systems, we made use of EXAFS and DFT calculations to confirm that i) Ga(III)-ME0163 complexation was effectively achieved and ii) to provide complementary characterization of the bonding environment of Ga(III) and ME0163.
EXAFS data for a sample at pH 10.6 (N1) was successfully modeled with only a first coordination shell consisting of 3.9 O/N at a distance of 1. 84 Å in accordance with the Ga-O distances in Ga(OH) 4 − ( Fig. 5 ; Table S3 ). Thus, at this pH there was no or only minor complex formation between Ga(III) and the hydrazone ligand and Ga(III) exists as a soluble hydroxo-complex, in agreement with the thermodynamic model in Hakobyan et al. [44] (Fig. 4a) . For samples at pH 8.9 and 7.9 (N2 and N3) a model with 1 O/N distance in the first shell resulted in a poor fit indicating a distorted first shell or that several Ga(III) species are present in the samples. The fit was significantly improved by introducing a second Ga-O/N distance and the two obtained distances (1.83-1.85 Å and 1.95 Å) were in accordance with Ga-O distances in four-coordinated Ga(OH) 4 − and in six-coordinated Ga(NO) 3 (aq). The coordination number (CN) obtained for the longer Ga-O/N path was higher in both of these samples suggesting that 6-coordinated Ga(III) species dominated (Table S3 ) and illustrating a large change in Ga(III) speciation as pH is decreased. Furthermore, at the lower-pH samples Ga-C/N interactions were detected in the second coordination shell showing that Ga(III) forms inner-sphere complexes with the hydrazone ligand. The Ga-C/N distances obtained (2.95-2.96 Å) are fairly close to Ga-C distances in Ga(III)-citrate (2.73-2.93 Å), where Ga(III) is complexed by both 5-and 6-membered chelate rings [37] , thus in a coordination motif similar to that expected for the Ga(III)-hydrazone complex (based on crystal structure of a Cu-hydrazone complex [46] ) and, b) a) Fig. 4 . a) Speciation diagram calculated from formation constants [44] for EXAFS sample N2 containing 1.89 mM Ga(III); b) geometry of a representative neutrally-charged Ga(III)-ME0163 complex showing distances from the DFT calculations.
again, in accordance with Hakobyan et al. [44] . Since the only possible ligands available to coordinate Ga(III) in the EXAFS solutions were H 2 O, OH − and ME0163, these data clearly indicate a direct interaction between Ga(III) and the hydrazone in the lower-pH samples.
In an effort to constrain our understanding of this complex further, DFT calculations were performed. We chose to study the neutrallycharged Ga(OH) In addition to the Ga(III)-ME0163 complex, EXAFS also provided evidence for Ga-Ga interactions with distances that are highly comparable to those occurring in Ga(OH) 3 (s) ( Table S3 ). Formation constants from Hakobyan et al. [44] suggest that small amounts of GaOOH(s) should be formed at pH lower than 8.5 at these Ga(III) concentrations (Fig. 4a ). However, it is possible that an amorphous Ga(OH) 3 (s) phase was formed with a different solubility to the crystalline GaOOH(s) used in speciation determinations in Hakobyan et al. [44] . The EXAFS samples were analyzed five days after sample preparation whereas the equilibrium data in Hakobyan et al. were determined at shorter equilibrium times (4 h). Furthermore, the concentrations in the EXAFS samples were higher (1.8 mM vs. 50 μM). Thus, it is possible that an amorphous solid phase could have been formed after 5 days at the higher concentrations in the EXAFS samples even if it did not form during titrations at 50 μM described in Hakobyan et al. [44] .
Gallium complexes inhibit the expression of virulence factors
To study the induction and activity of T3SS in the presence of ME0163 and Ga(III)-ME0163 we measured expression and secretion of ExoS, a toxin secreted by the T3SS. Cultures of equal optical density i.e. equal number of bacterial cells were used for all experimental conditions. ExoS expression and secretion in the presence of ME0163 were similar to control (Fig. 6a and b) which is in agreement with data obtained with Yersinia pseudotuberculosis [26] . In contrast, both Ga(III)-citrate and Ga(III)-ME0163 expression and secretion of ExoS dramatically dropped to low or undetectable levels ( Fig. 6a and b) . Our conclusion is that the T3SS is not completely shut down but strongly suppressed in the presence of Ga(III) complexes. Previously, we have observed an altered protein expression pattern in P. aeruginosa in the presence of Ga(III) [21] . However, this is the first report on suppression of such an important virulence factor as T3SS by Ga(III) complexes. The suppression is obviously selective as the levels of FliC protein in the same samples were not changed. Selective inhibition of T3SS implies that even though bacteria are able to multiply at a given concentration of the compound, their ability to damage the host cells is much weakened through the presence of Ga(III).
Conclusions
In this study we have shown that Ga(III) forms a complex with the hydrazone ME0163 exhibiting two chelating rings. This Ga(III)-ME0163 complex was found to have an enhanced anti-biofilm effect in low Fe(III) conditions but this effect disappeared in 100% ISO-SENSITEST medium where Fe(III) was presumably present at high enough levels to counteract the Fe antagonist effect. While ME0163 alone did not have a large effect on the T3SS in P. aeruginosa, we observed that Ga(III)-ME0163 and Ga(III)-citrate suppressed expression and secretion of the T3SS effector protein ExoS. To the best of our knowledge, this work is the first to present Ga(III) complexes that suppress the T3SS in bacteria. Thus, this study opens up for new approaches to target virulence in the form of T3SS in bacteria. 
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